- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Influenza Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 3889.8 million by 2025, from USD 3259.7 million in 2019.
Market segmentation
Influenza Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Influenza Vaccines market has been segmented into
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
By Application, Influenza Vaccines has been segmented into:
Adults
Pediatrics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Influenza Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Influenza Vaccines Market Share Analysis
Influenza Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenza Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Influenza Vaccines are:
AstraZeneca
FOLIA BIOTECH
Sanofi
CSL
FluGen
GlaxoSmithKline
Green Cross
BionVax
Altimmune
Genentech
SK Chemicals
Vaxart
Medicago
Visterra
UNM Pharma
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
Vaxine Pty
Vaccitech
Novavax
Among other players domestic and global, Influenza Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Vaccines, with price, sales, revenue and global market share of Influenza Vaccines in 2018 and 2019.
Chapter 3, the Influenza Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Influenza Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trivalent Flu Vaccines
1.2.3 Quadrivalent Flu Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Pediatrics
1.4 Overview of Global Influenza Vaccines Market
1.4.1 Global Influenza Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 FOLIA BIOTECH
2.2.1 FOLIA BIOTECH Details
2.2.2 FOLIA BIOTECH Major Business
2.2.3 FOLIA BIOTECH SWOT Analysis
2.2.4 FOLIA BIOTECH Product and Services
2.2.5 FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL SWOT Analysis
2.4.4 CSL Product and Services
2.4.5 CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 FluGen
2.5.1 FluGen Details
2.5.2 FluGen Major Business
2.5.3 FluGen SWOT Analysis
2.5.4 FluGen Product and Services
2.5.5 FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Product and Services
2.6.4 GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Green Cross
2.7.1 Green Cross Details
2.7.2 Green Cross Major Business
2.7.3 Green Cross Product and Services
2.7.4 Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BionVax
2.8.1 BionVax Details
2.8.2 BionVax Major Business
2.8.3 BionVax Product and Services
2.8.4 BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Altimmune
2.9.1 Altimmune Details
2.9.2 Altimmune Major Business
2.9.3 Altimmune Product and Services
2.9.4 Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business
2.10.3 Genentech Product and Services
2.10.4 Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 SK Chemicals
2.11.1 SK Chemicals Details
2.11.2 SK Chemicals Major Business
2.11.3 SK Chemicals Product and Services
2.11.4 SK Chemicals Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vaxart
2.12.1 Vaxart Details
2.12.2 Vaxart Major Business
2.12.3 Vaxart Product and Services
2.12.4 Vaxart Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Medicago
2.13.1 Medicago Details
2.13.2 Medicago Major Business
2.13.3 Medicago Product and Services
2.13.4 Medicago Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Visterra
2.14.1 Visterra Details
2.14.2 Visterra Major Business
2.14.3 Visterra Product and Services
2.14.4 Visterra Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 UNM Pharma
2.15.1 UNM Pharma Details
2.15.2 UNM Pharma Major Business
2.15.3 UNM Pharma Product and Services
2.15.4 UNM Pharma Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Shijiazhuang Yiling Pharmaceutical
2.16.1 Shijiazhuang Yiling Pharmaceutical Details
2.16.2 Shijiazhuang Yiling Pharmaceutical Major Business
2.16.3 Shijiazhuang Yiling Pharmaceutical Product and Services
2.16.4 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Moderna Therapeutics
2.17.1 Moderna Therapeutics Details
2.17.2 Moderna Therapeutics Major Business
2.17.3 Moderna Therapeutics Product and Services
2.17.4 Moderna Therapeutics Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Vaxine Pty
2.18.1 Vaxine Pty Details
2.18.2 Vaxine Pty Major Business
2.18.3 Vaxine Pty Product and Services
2.18.4 Vaxine Pty Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Vaccitech
2.19.1 Vaccitech Details
2.19.2 Vaccitech Major Business
2.19.3 Vaccitech Product and Services
2.19.4 Vaccitech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Novavax
2.20.1 Novavax Details
2.20.2 Novavax Major Business
2.20.3 Novavax Product and Services
2.20.4 Novavax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Influenza Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Influenza Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Influenza Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Influenza Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Influenza Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Influenza Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Influenza Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenza Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Influenza Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Influenza Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Influenza Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenza Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Influenza Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Influenza Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Influenza Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Influenza Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Influenza Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Influenza Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Influenza Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Influenza Vaccines Sales and Growth Rate (2015-2020)
6.4 France Influenza Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Influenza Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Influenza Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenza Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Influenza Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Influenza Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Influenza Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Influenza Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Influenza Vaccines Sales and Growth Rate (2015-2020)
7.5 India Influenza Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Influenza Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Influenza Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Influenza Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Influenza Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Influenza Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Influenza Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Influenza Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenza Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Influenza Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Influenza Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Influenza Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Influenza Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Influenza Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Influenza Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Influenza Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Influenza Vaccines Price by Type (2015-2020)
11 Global Influenza Vaccines Market Segment by Application
11.1 Global Influenza Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Influenza Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Influenza Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Influenza Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Influenza Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Influenza Vaccines Market Forecast (2021-2025)
12.2.2 Europe Influenza Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Influenza Vaccines Market Forecast (2021-2025)
12.2.4 South America Influenza Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Influenza Vaccines Market Forecast (2021-2025)
12.3 Influenza Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Influenza Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Influenza Vaccines Market Share Forecast by Type (2021-2025)
12.4 Influenza Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Influenza Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Influenza Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Influenza Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza Vaccines Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Influenza Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Influenza Vaccines Major Business
Table 10. AstraZeneca Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Influenza Vaccines Product and Services
Table 13. AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. FOLIA BIOTECH Basic Information, Manufacturing Base and Competitors
Table 15. FOLIA BIOTECH Influenza Vaccines Major Business
Table 16. FOLIA BIOTECH Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 17. FOLIA BIOTECH SWOT Analysis
Table 18. FOLIA BIOTECH Influenza Vaccines Product and Services
Table 19. FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sanofi Basic Information, Manufacturing Base and Competitors
Table 21. Sanofi Influenza Vaccines Major Business
Table 22. Sanofi Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 23. Sanofi SWOT Analysis
Table 24. Sanofi Influenza Vaccines Product and Services
Table 25. Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CSL Basic Information, Manufacturing Base and Competitors
Table 27. CSL Influenza Vaccines Major Business
Table 28. CSL Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 29. CSL SWOT Analysis
Table 30. CSL Influenza Vaccines Product and Services
Table 31. CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. FluGen Basic Information, Manufacturing Base and Competitors
Table 33. FluGen Influenza Vaccines Major Business
Table 34. FluGen Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 35. FluGen SWOT Analysis
Table 36. FluGen Influenza Vaccines Product and Services
Table 37. FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Influenza Vaccines Major Business
Table 40. GlaxoSmithKline Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 41. GlaxoSmithKline SWOT Analysis
Table 42. GlaxoSmithKline Influenza Vaccines Product and Services
Table 43. GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Green Cross Basic Information, Manufacturing Base and Competitors
Table 45. Green Cross Influenza Vaccines Major Business
Table 46. Green Cross Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 47. Green Cross SWOT Analysis
Table 48. Green Cross Influenza Vaccines Product and Services
Table 49. Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. BionVax Basic Information, Manufacturing Base and Competitors
Table 51. BionVax Influenza Vaccines Major Business
Table 52. BionVax Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 53. BionVax SWOT Analysis
Table 54. BionVax Influenza Vaccines Product and Services
Table 55. BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Altimmune Basic Information, Manufacturing Base and Competitors
Table 57. Altimmune Influenza Vaccines Major Business
Table 58. Altimmune Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 59. Altimmune SWOT Analysis
Table 60. Altimmune Influenza Vaccines Product and Services
Table 61. Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Genentech Basic Information, Manufacturing Base and Competitors
Table 63. Genentech Influenza Vaccines Major Business
Table 64. Genentech Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 65. Genentech SWOT Analysis
Table 66. Genentech Influenza Vaccines Product and Services
Table 67. Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. SK Chemicals Basic Information, Manufacturing Base and Competitors
Table 69. SK Chemicals Influenza Vaccines Major Business
Table 70. SK Chemicals Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 71. SK Chemicals SWOT Analysis
Table 72. SK Chemicals Influenza Vaccines Product and Services
Table 73. SK Chemicals Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Vaxart Basic Information, Manufacturing Base and Competitors
Table 75. Vaxart Influenza Vaccines Major Business
Table 76. Vaxart Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 77. Vaxart SWOT Analysis
Table 78. Vaxart Influenza Vaccines Product and Services
Table 79. Vaxart Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Medicago Basic Information, Manufacturing Base and Competitors
Table 81. Medicago Influenza Vaccines Major Business
Table 82. Medicago Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 83. Medicago SWOT Analysis
Table 84. Medicago Influenza Vaccines Product and Services
Table 85. Medicago Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Visterra Basic Information, Manufacturing Base and Competitors
Table 87. Visterra Influenza Vaccines Major Business
Table 88. Visterra Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 89. Visterra SWOT Analysis
Table 90. Visterra Influenza Vaccines Product and Services
Table 91. Visterra Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. UNM Pharma Basic Information, Manufacturing Base and Competitors
Table 93. UNM Pharma Influenza Vaccines Major Business
Table 94. UNM Pharma Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 95. UNM Pharma SWOT Analysis
Table 96. UNM Pharma Influenza Vaccines Product and Services
Table 97. UNM Pharma Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Major Business
Table 100. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 101. Shijiazhuang Yiling Pharmaceutical SWOT Analysis
Table 102. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product and Services
Table 103. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 105. Moderna Therapeutics Influenza Vaccines Major Business
Table 106. Moderna Therapeutics Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 107. Moderna Therapeutics SWOT Analysis
Table 108. Moderna Therapeutics Influenza Vaccines Product and Services
Table 109. Moderna Therapeutics Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Vaxine Pty Influenza Vaccines Type and Application
Table 111. Vaxine Pty Influenza Vaccines Major Business
Table 112. Vaxine Pty Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 113. Vaxine Pty SWOT Analysis
Table 114. Vaxine Pty Influenza Vaccines Product and Services
Table 115. Vaxine Pty Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Vaccitech Basic Information, Manufacturing Base and Competitors
Table 117. Vaccitech Influenza Vaccines Major Business
Table 118. Vaccitech Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 119. Vaccitech SWOT Analysis
Table 120. Vaccitech Influenza Vaccines Product and Services
Table 121. Vaccitech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Novavax Basic Information, Manufacturing Base and Competitors
Table 123. Novavax Influenza Vaccines Major Business
Table 124. Novavax Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 125. Novavax SWOT Analysis
Table 126. Novavax Influenza Vaccines Product and Services
Table 127. Novavax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 128. Global Influenza Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 129. Global Influenza Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 130. Global Influenza Vaccines Sales by Regions (2015-2020) (K Units)
Table 131. Global Influenza Vaccines Sales Market Share by Regions (2015-2020)
Table 132. Global Influenza Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 133. North America Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 134. North America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 135. North America Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 136. North America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 137. Europe Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 138. Europe Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 139. Europe Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 140. Asia-Pacific Influenza Vaccines Sales by Regions (2015-2020) (K Units)
Table 141. Asia-Pacific Influenza Vaccines Sales Market Share by Regions (2015-2020)
Table 142. Asia-Pacific Influenza Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 143. South America Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 144. South America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 145. South America Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 146. South America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 147. Middle East & Africa Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 148. Middle East & Africa Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 149. Middle East & Africa Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 150. Middle East & Africa Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 151. Global Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 152. Global Influenza Vaccines Sales Share by Type (2015-2020)
Table 153. Global Influenza Vaccines Revenue by Type (2015-2020) (USD Million)
Table 154. Global Influenza Vaccines Revenue Share by Type (2015-2020)
Table 155. Global Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 156. Global Influenza Vaccines Sales Share by Application (2015-2020)
Table 157. Global Influenza Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 158. Global Influenza Vaccines Market Share Forecast by Regions (2021-2025)
Table 159. Global Influenza Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 160. Global Influenza Vaccines Market Share Forecast by Type (2021-2025)
Table 161. Global Influenza Vaccines Sales Forecast by Application (2021-2025)
Table 162. Global Influenza Vaccines Market Share Forecast by Application (2021-2025)
Table 163. Direct Channel Pros & Cons
Table 164. Indirect Channel Pros & Cons
Table 165. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Influenza Vaccines Picture
Figure 2. Global Sales Market Share of Influenza Vaccines by Type in 2019
Figure 3. Trivalent Flu Vaccines Picture
Figure 4. Quadrivalent Flu Vaccines Picture
Figure 5. Influenza Vaccines Sales Market Share by Application in 2019
Figure 6. Adults Picture
Figure 7. Pediatrics Picture
Figure 8. Global Influenza Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Influenza Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Influenza Vaccines Sales Market Share by Manufacturer in 2019
Figure 29. Global Influenza Vaccines Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Influenza Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Influenza Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Influenza Vaccines Revenue Market Share by Regions (2015-2020)
Figure 36. Global Influenza Vaccines Revenue Market Share by Regions in 2018
Figure 37. North America Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure 38. Europe Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure 40. South America Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
Figure 42. North America Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Figure 44. North America Influenza Vaccines Sales Market Share by Countries in 2018
Figure 45. North America Influenza Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Influenza Vaccines Revenue Market Share by Countries in 2018
Figure 47. United States Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Influenza Vaccines Revenue Market Share by Countries in 2019
Figure 53. Germany Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Influenza Vaccines Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Influenza Vaccines Revenue Market Share by Regions 2019
Figure 61. China Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Influenza Vaccines Sales Market Share by Countries in 2019
Figure 68. South America Influenza Vaccines Revenue Market Share by Countries in 2019
Figure 69. Brazil Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Influenza Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Influenza Vaccines Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Influenza Vaccines Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Influenza Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Influenza Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Influenza Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Influenza Vaccines Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Influenza Vaccines Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Influenza Vaccines Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Influenza Vaccines Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Influenza Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
